Screener
Carlsmed, Inc. CARL Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Carlsmed, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001794546-26-000016
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net loss | $(19,206) | $(12,495) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 229 | 101 |
| Stock-based compensation | 3,900 | 433 |
| Non-cash interest | 72 | 108 |
| Gain on termination of lease | (52) | — |
| Loss on remeasurement of warrant liabilities | — | 270 |
| Non-cash lease expense | 399 | 219 |
Item 1. Financial Statements.
FAQ
- What is Carlsmed, Inc.'s stock-based comp?
- Carlsmed, Inc. (CARL) reported stock-based comp of $2.27M in Q2 2026.
- How has Carlsmed, Inc.'s stock-based comp changed year-over-year?
- Carlsmed, Inc.'s stock-based comp increased by 780.2% year-over-year, from $258K to $2.27M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Carlsmed, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude